US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 17.140
  • -1.450-7.80%
Close Aug 16 16:00 ET
  • 17.140
  • 0.0000.00%
Post 20:02 ET
440.90MMarket Cap-22317P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-120.90%-8.5M
-52.08%-7.98M
196.16%19.35M
-162.61%-10.7M
-5.38M
40.67M
-5.24M
23.40%-20.12M
-4.08M
-26.27M
Net income from continuing operations
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
---6.25M
--41.56M
---4.82M
16.37%-24.25M
---7.51M
---29M
Operating gains losses
----
387.50%117K
300.00%14K
-100.00%-6K
---4K
--0
--24K
-250.00%-7K
---3K
---2K
Depreciation and amortization
42.86%60K
-16.44%61K
-40.73%195K
-54.32%37K
--43K
--42K
--73K
1.23%329K
--81K
--325K
Other non cash items
112.26%351K
-7.58%244K
-172.46%-2.1M
-89.73%263K
--236K
---2.86M
--264K
1,667.07%2.9M
--2.56M
--164K
Change In working capital
-112.58%-209K
127.12%275K
19.18%-1.02M
-765.87%-2.79M
--1.12M
--1.66M
---1.01M
-1,273.15%-1.27M
--419K
--108K
-Change in prepaid assets
189.13%133K
1,288.33%713K
-237.83%-1.28M
-131.17%-24K
---1.24M
--46K
---60K
-0.53%-378K
--77K
---376K
-Change in payables and accrued expense
-170.16%-1.29M
35.34%-450K
2,244.12%1.59M
-450.63%-2.23M
--2.68M
--1.84M
---696K
-80.90%68K
--636K
--356K
-Change in other current assets
3,127.59%936K
--0
121.88%7K
203.13%33K
---60K
--29K
--5K
-300.00%-32K
---32K
--16K
-Change in other current liabilities
105.12%13K
104.56%12K
-45.73%-1.35M
-90.40%-1.35M
--517K
---254K
---263K
-925.89%-925K
---708K
--112K
Cash from discontinued investing activities
Operating cash flow
-120.90%-8.5M
-52.08%-7.98M
196.16%19.35M
-162.55%-10.7M
---5.38M
--40.67M
---5.24M
23.40%-20.12M
---4.08M
---26.27M
Investing cash flow
Cash flow from continuing investing activities
12.50%-38.9M
-6.67%8.73M
-394.04%-65.57M
83.65%9.03M
-39.5M
-44.46M
9.36M
134.32%22.3M
4.92M
-64.97M
Net PPE purchase and sale
-283.87%-119K
-182.69%-147K
-250.85%-414K
---309K
---22K
---31K
---52K
29.76%-118K
--0
---168K
Net investment purchase and sale
12.71%-38.78M
-5.62%8.88M
-390.65%-65.15M
89.93%9.34M
---39.47M
---44.43M
--9.41M
134.59%22.42M
--4.92M
---64.8M
Cash from discontinued investing activities
Investing cash flow
12.50%-38.9M
-6.67%8.73M
-394.04%-65.57M
83.65%9.03M
---39.5M
---44.46M
--9.36M
134.32%22.3M
--4.92M
---64.97M
Financing cash flow
Cash flow from continuing financing activities
131.60%108.36M
97.08%-18K
4,633.98%56.18M
48.64%-321K
10.33M
46.79M
-617K
-101.55%-1.24M
-625K
79.84M
Net issuance payments of debt
--0
--0
-200.00%-3.75M
--0
--0
---3.13M
---625K
---1.25M
---625K
--0
Net common stock issuance
----
----
-600.00%-28K
--1K
---29K
----
----
---4K
--0
--0
Net preferred stock issuance
----
----
--60.14M
--0
--10.24M
----
----
--0
--0
--79.73M
Proceeds from stock option exercised by employees
-31.58%13K
1,425.00%122K
960.00%159K
--21K
--111K
--19K
--8K
-86.73%15K
--0
--113K
Net other financing activities
----
---140K
---343K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
131.60%108.36M
97.08%-18K
4,633.98%56.18M
48.64%-321K
--10.33M
--46.79M
---617K
-101.55%-1.24M
---625K
--79.84M
Net cash flow
Beginning cash position
79.45%16.26M
178.79%15.53M
20.28%5.57M
227.25%17.52M
--52.07M
--9.06M
--5.57M
-71.11%4.63M
--5.35M
--16.03M
Current changes in cash
41.76%60.97M
-78.88%738K
960.38%9.96M
-1,027.91%-2M
---34.55M
--43.01M
--3.49M
108.24%939K
--215K
---11.4M
End cash Position
48.32%77.23M
79.45%16.26M
178.79%15.53M
178.79%15.53M
--17.52M
--52.07M
--9.06M
20.28%5.57M
--5.57M
--4.63M
Free cash flow
-121.20%-8.62M
-53.36%-8.12M
193.56%18.94M
-170.13%-11.01M
---5.4M
--40.64M
---5.3M
23.44%-20.24M
---4.08M
---26.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -120.90%-8.5M-52.08%-7.98M196.16%19.35M-162.61%-10.7M-5.38M40.67M-5.24M23.40%-20.12M-4.08M-26.27M
Net income from continuing operations -121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M---6.25M--41.56M---4.82M16.37%-24.25M---7.51M---29M
Operating gains losses ----387.50%117K300.00%14K-100.00%-6K---4K--0--24K-250.00%-7K---3K---2K
Depreciation and amortization 42.86%60K-16.44%61K-40.73%195K-54.32%37K--43K--42K--73K1.23%329K--81K--325K
Other non cash items 112.26%351K-7.58%244K-172.46%-2.1M-89.73%263K--236K---2.86M--264K1,667.07%2.9M--2.56M--164K
Change In working capital -112.58%-209K127.12%275K19.18%-1.02M-765.87%-2.79M--1.12M--1.66M---1.01M-1,273.15%-1.27M--419K--108K
-Change in prepaid assets 189.13%133K1,288.33%713K-237.83%-1.28M-131.17%-24K---1.24M--46K---60K-0.53%-378K--77K---376K
-Change in payables and accrued expense -170.16%-1.29M35.34%-450K2,244.12%1.59M-450.63%-2.23M--2.68M--1.84M---696K-80.90%68K--636K--356K
-Change in other current assets 3,127.59%936K--0121.88%7K203.13%33K---60K--29K--5K-300.00%-32K---32K--16K
-Change in other current liabilities 105.12%13K104.56%12K-45.73%-1.35M-90.40%-1.35M--517K---254K---263K-925.89%-925K---708K--112K
Cash from discontinued investing activities
Operating cash flow -120.90%-8.5M-52.08%-7.98M196.16%19.35M-162.55%-10.7M---5.38M--40.67M---5.24M23.40%-20.12M---4.08M---26.27M
Investing cash flow
Cash flow from continuing investing activities 12.50%-38.9M-6.67%8.73M-394.04%-65.57M83.65%9.03M-39.5M-44.46M9.36M134.32%22.3M4.92M-64.97M
Net PPE purchase and sale -283.87%-119K-182.69%-147K-250.85%-414K---309K---22K---31K---52K29.76%-118K--0---168K
Net investment purchase and sale 12.71%-38.78M-5.62%8.88M-390.65%-65.15M89.93%9.34M---39.47M---44.43M--9.41M134.59%22.42M--4.92M---64.8M
Cash from discontinued investing activities
Investing cash flow 12.50%-38.9M-6.67%8.73M-394.04%-65.57M83.65%9.03M---39.5M---44.46M--9.36M134.32%22.3M--4.92M---64.97M
Financing cash flow
Cash flow from continuing financing activities 131.60%108.36M97.08%-18K4,633.98%56.18M48.64%-321K10.33M46.79M-617K-101.55%-1.24M-625K79.84M
Net issuance payments of debt --0--0-200.00%-3.75M--0--0---3.13M---625K---1.25M---625K--0
Net common stock issuance ---------600.00%-28K--1K---29K-----------4K--0--0
Net preferred stock issuance ----------60.14M--0--10.24M----------0--0--79.73M
Proceeds from stock option exercised by employees -31.58%13K1,425.00%122K960.00%159K--21K--111K--19K--8K-86.73%15K--0--113K
Net other financing activities -------140K---343K----------------------------
Cash from discontinued financing activities
Financing cash flow 131.60%108.36M97.08%-18K4,633.98%56.18M48.64%-321K--10.33M--46.79M---617K-101.55%-1.24M---625K--79.84M
Net cash flow
Beginning cash position 79.45%16.26M178.79%15.53M20.28%5.57M227.25%17.52M--52.07M--9.06M--5.57M-71.11%4.63M--5.35M--16.03M
Current changes in cash 41.76%60.97M-78.88%738K960.38%9.96M-1,027.91%-2M---34.55M--43.01M--3.49M108.24%939K--215K---11.4M
End cash Position 48.32%77.23M79.45%16.26M178.79%15.53M178.79%15.53M--17.52M--52.07M--9.06M20.28%5.57M--5.57M--4.63M
Free cash flow -121.20%-8.62M-53.36%-8.12M193.56%18.94M-170.13%-11.01M---5.4M--40.64M---5.3M23.44%-20.24M---4.08M---26.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Recent IPOs
Recent IPOs
Intraday-0.37%